JP MORGAN/PUT/TEVA PHARMACEUTICAL INDUSTRIES/11/1/20.09.24 Share Price

Warrant

DE000JK0SC84

Market Closed - Börse Stuttgart 11:08:18 25/06/2024 BST
0.043 EUR +4.88% Intraday chart for JP MORGAN/PUT/TEVA PHARMACEUTICAL INDUSTRIES/11/1/20.09.24
Current month-10.42%
1 month-10.42%
Date Price Change
25/06/24 0.043 +4.88%
24/06/24 0.041 -4.65%
21/06/24 0.043 -8.51%
20/06/24 0.047 -2.08%
19/06/24 0.048 -4.00%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 11:08 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer J.P. Morgan
WKN JK0SC8
ISINDE000JK0SC84
Date issued 25/01/2024
Strike 11 $
Maturity 20/09/2024 (86 Days)
Parity 1 : 1
Emission price 0.84
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.95
Lowest since issue 0.041
Delta-0.11x
Omega 4.354
Premium34.88x
Gearing38.82x
Moneyness 0.6769
Difference Strike -5.25 $
Difference Strike %-47.73%
Spread 0.696
Spread %94.05%
Theoretical value 0.3920
Implied Volatility 81.40 %
Total Loss Probability 79.35 %
Intrinsic value 0.000000
Present value 0.3920
Break even 10.58 €
Theta-0.04x
Vega0.01x
Rho-0x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.25 USD
Average target price
18.34 USD
Spread / Average Target
+12.84%
Consensus